Please ensure Javascript is enabled for purposes of website accessibility

Canopy Growth Partners With Univo Pharmaceuticals to Sell Cannabis in Israel

By David Jagielski - Mar 2, 2020 at 3:18PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The agreement also gives the cannabis producer the ability to export products from Israel to Europe.

Israeli-based Univo Pharmaceuticals announced this week that it had signed a memorandum of understanding with cannabis producer Canopy Growth (CGC -1.40%) that would see the two companies work together on the sale, production, and marketing of medical marijuana in Israel. 

Univo will initially import 470 kilograms of dry cannabis from the Canadian producer, which it will also use to manufacture cannabis products that will be sold under a joint brand and logo.

At a later stage in the agreement, and once it's legal to do so, Canopy Growth will use Univo's location in Ashkelon, Israel, to manufacture and process cannabis products for export to Europe.

In January, Israeli producer Canndoc imported the country's first-ever commercial medical cannabis shipment from a production plant in Portgual owned by another Canadian-based producer, Tilray (TLRY)

View of Europe from the sky at night.

Image source: Getty Images.

Canopy Growth remains one of the industry's top pot stocks

When Canopy Growth released its quarterly results on Feb. 14, it proved to investors that it was still among the best in the industry. With sales growth of 49% from the prior-year quarter and 62% improvement from the prior period, the company thoroughly beat analysts' consensus expectations. 

That was a stark contrast to one of its main rivals, Aurora Cannabis (ACB 2.27%), which disappointed its investors with falling sales in its most recent results, and said that it expects "modest to no growth" in its next quarter. 

Both cannabis companies have undergone changes in leadership over the past year, and with Canopy Growth now under the direction of Constellation Brands' (STZ 1.02%) former CFO David Klein, the company is committed to strengthening its bottom line. It has reported losses in four consecutive quarters. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Canopy Growth Stock Quote
Canopy Growth
CGC
$2.81 (-1.40%) $0.04
Constellation Brands, Inc. Stock Quote
Constellation Brands, Inc.
STZ
$235.43 (1.02%) $2.37
Aurora Cannabis Stock Quote
Aurora Cannabis
ACB
$1.35 (2.27%) $0.03
Tilray Stock Quote
Tilray
TLRY

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
316%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/02/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.